ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results

ConforMIS (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient’s unique anatomy, announced today financial results for the fourth quarter and the year ended December 31, 2017.

As quoted in the press release:

Total revenue of $78.1 million, down 2% year-over-year on a reported and constant currency basisProduct revenue of $77.1 million, down 2% year-over-year on a reported and constant currency basis. U.S. product revenue of $64.4 million, up 3% year-over-year. Rest of World product revenue of $12.7 million, down 23% year-over-year on a reported basis and 22% year-over-year on a constant currency basis.

Click here to read the full press release.